星空体育官方入口网站网址大全-登录入口官网

#生物制药#

51篇内容 | 1501人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2181423, encodeId=ff3221814235b, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a> <a href='/topic/show?id=026711006432' target=_blank style='color:#2F92EE;'>#JPM大会#</a>, objectTitle=JPM大会为2024年指明方向：谷底转折，全球生物制药终将向上发展, objectType=article, longId=809297, objectId=fe3e80929ea9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240113/1705138036996_92910.png, objectUrl=/article/show_article.do?id=fe3e80929ea9, replyNumber=0, likeNumber=51, createdTime=2024-01-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fe3e80929ea9, moduleTitle=JPM大会为2024年指明方向：谷底转折，全球生物制药终将向上发展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fe3e80929ea9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1387677, encodeId=23af138e67790, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=新药进展 | 治疗慢性咳嗽！中国生物制药自研1类新药P2X3受体拮抗剂获批临床, objectType=article, longId=292525, objectId=566729252516, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=566729252516, replyNumber=0, likeNumber=106, createdTime=2021-12-24, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=566729252516, moduleTitle=新药进展 | 治疗慢性咳嗽！中国生物制药自研1类新药P2X3受体拮抗剂获批临床, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=566729252516)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387676, encodeId=7ad9138e676f2, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=勃林格殷格翰收购生物制药公司 Abexxa Biologics, objectType=article, longId=217712, objectId=c31021e712b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c31021e712b2, replyNumber=0, likeNumber=67, createdTime=2021-09-28, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c31021e712b2, moduleTitle=勃林格殷格翰收购生物制药公司 Abexxa Biologics, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c31021e712b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387675, encodeId=2978138e6758a, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=15亿美元再下赌注！中国生物制药创新如何扬帆破浪？, objectType=article, longId=217307, objectId=e70321e30778, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e70321e30778, replyNumber=0, likeNumber=71, createdTime=2021-09-20, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e70321e30778, moduleTitle=15亿美元再下赌注！中国生物制药创新如何扬帆破浪？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e70321e30778)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387674, encodeId=0fa5138e674a8, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=赛诺菲宣布以19亿美元收购美国生物制药公司KDMN，盘前大涨77%！, objectType=article, longId=216857, objectId=6e6c21685e21, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e6c21685e21, replyNumber=0, likeNumber=74, createdTime=2021-09-10, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e6c21685e21, moduleTitle=赛诺菲宣布以19亿美元收购美国生物制药公司KDMN，盘前大涨77%！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6e6c21685e21)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387673, encodeId=3270138e673fc, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=周报：全球新冠大流行推高生物制药股票10.6%, objectType=article, longId=216426, objectId=719e21642660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=719e21642660, replyNumber=0, likeNumber=71, createdTime=2021-08-30, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=719e21642660, moduleTitle=周报：全球新冠大流行推高生物制药股票10.6%, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=719e21642660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387672, encodeId=1d83138e672ff, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=PD-1/L1竞争再加剧，中国生物制药与康方生物研发的治疗鼻咽癌新药上市申请获国家药监局受理, objectType=article, longId=215388, objectId=bc0f21538845, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc0f21538845, replyNumber=0, likeNumber=72, createdTime=2021-08-08, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc0f21538845, moduleTitle=PD-1/L1竞争再加剧，中国生物制药与康方生物研发的治疗鼻咽癌新药上市申请获国家药监局受理, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bc0f21538845)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387671, encodeId=23c5138e67151, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=助力生物制药关键材料国产化，红杉医疗成员企业纳微科技成功IPO, objectType=article, longId=213102, objectId=02e4213102f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02e4213102f5, replyNumber=0, likeNumber=67, createdTime=2021-06-25, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02e4213102f5, moduleTitle=助力生物制药关键材料国产化，红杉医疗成员企业纳微科技成功IPO, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=02e4213102f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387670, encodeId=5334138e67013, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=临床阶段生物制药公司宣布开展卡妥索双抗治疗非肌层浸润性膀胱癌临床I/II期试验, objectType=article, longId=209970, objectId=4f092099e063, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f092099e063, replyNumber=0, likeNumber=63, createdTime=2021-04-16, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f092099e063, moduleTitle=临床阶段生物制药公司宣布开展卡妥索双抗治疗非肌层浸润性膀胱癌临床I/II期试验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4f092099e063)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387669, encodeId=5928138e6694b, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=超过20家生物制药公司港股上市，如何走出破发怪圈, objectType=article, longId=204166, objectId=9165204166bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9165204166bc, replyNumber=0, likeNumber=70, createdTime=2020-12-07, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9165204166bc, moduleTitle=超过20家生物制药公司港股上市，如何走出破发怪圈, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9165204166bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387668, encodeId=74d6138e66840, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=SciVario® twin双联生物反应器重磅上市，助力生物制药行业高质量发展, objectType=article, longId=203224, objectId=ebbd20322403, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebbd20322403, replyNumber=0, likeNumber=55, createdTime=2020-11-11, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebbd20322403, moduleTitle=SciVario® twin双联生物反应器重磅上市，助力生物制药行业高质量发展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ebbd20322403)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387667, encodeId=42b2138e66793, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=重磅！默沙东将分拆为两家公司，专注研发创新生物制药, objectType=article, longId=187562, objectId=75ea18e562d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75ea18e562d0, replyNumber=0, likeNumber=65, createdTime=2020-02-07, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75ea18e562d0, moduleTitle=重磅！默沙东将分拆为两家公司，专注研发创新生物制药, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=75ea18e562d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387666, encodeId=622e138e66629, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=三叶草生物制药在中国启动Etanercept生物类似物候选产品SCB-808的III期研究, objectType=article, longId=185519, objectId=938918551947, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=938918551947, replyNumber=0, likeNumber=66, createdTime=2020-01-02, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=938918551947, moduleTitle=三叶草生物制药在中国启动Etanercept生物类似物候选产品SCB-808的III期研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=938918551947)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387665, encodeId=0d8c138e66552, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=生物制药领域更具价值新药研发项目TOP10, objectType=article, longId=185250, objectId=b94618525047, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b94618525047, replyNumber=0, likeNumber=69, createdTime=2019-12-27, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b94618525047, moduleTitle=生物制药领域更具价值新药研发项目TOP10, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b94618525047)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387664, encodeId=9617138e664b6, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=Thermo Fisher在中国开设客户解决方案中心，以支持生物制药研发, objectType=article, longId=182987, objectId=ad9418298ebd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad9418298ebd, replyNumber=0, likeNumber=54, createdTime=2019-11-16, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad9418298ebd, moduleTitle=Thermo Fisher在中国开设客户解决方案中心，以支持生物制药研发, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ad9418298ebd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387663, encodeId=267e138e663b6, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=德国模式+张江制造：跨国药企在华生物制药商业化合同生产（CMO）服务平台亮相进博会, objectType=article, longId=182498, objectId=46e01824984a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46e01824984a, replyNumber=0, likeNumber=48, createdTime=2019-11-08, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46e01824984a, moduleTitle=德国模式+张江制造：跨国药企在华生物制药商业化合同生产（CMO）服务平台亮相进博会, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=46e01824984a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387662, encodeId=ac05138e66233, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=亚盛医药IPO敲定基石投资人，中国生物制药认购1.4亿元, objectType=article, longId=181420, objectId=3c2118142058, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c2118142058, replyNumber=0, likeNumber=66, createdTime=2019-10-18, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c2118142058, moduleTitle=亚盛医药IPO敲定基石投资人，中国生物制药认购1.4亿元, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3c2118142058)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387661, encodeId=8bee138e661b0, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=引领生物制药行业标准，加速高品质创新抗癌药惠及患者 ——百济神州广州生物药生产基地一期项目竣工, objectType=article, longId=180177, objectId=44071801e771, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44071801e771, replyNumber=0, likeNumber=64, createdTime=2019-09-29, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44071801e771, moduleTitle=引领生物制药行业标准，加速高品质创新抗癌药惠及患者 ——百济神州广州生物药生产基地一期项目竣工, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=44071801e771)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387660, encodeId=c1e1138e660cd, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=科伦、中国生物制药、信立泰……半年业绩大比拼, objectType=article, longId=178366, objectId=4ff41e836652, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ff41e836652, replyNumber=0, likeNumber=68, createdTime=2019-08-31, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ff41e836652, moduleTitle=科伦、中国生物制药、信立泰……半年业绩大比拼, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4ff41e836652)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387659, encodeId=1ddf138e659f4, content=<a href='/topic/show?id=75146922836' target=_blank style='color:#2F92EE;'>#生物制药#</a>, objectTitle=生物制药“名人堂”：史上销售额**的超重磅产品盘点, objectType=article, longId=177743, objectId=c6301e774337, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6301e774337, replyNumber=0, likeNumber=67, createdTime=2019-08-17, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6301e774337, moduleTitle=生物制药“名人堂”：史上销售额**的超重磅产品盘点, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c6301e774337)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生物制药

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#生物制药# #JPM大会#

JPM大会为2024年指明方向：谷底转折，全球生物制药终将向上发展

2024-01-13发表于上海

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

新药进展 | 治疗慢性咳嗽！中国生物制药自研1类新药P2X3受体拮抗剂获批临床

2021-12-24

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

勃林格殷格翰收购生物制药公司 Abexxa Biologics

2021-09-28

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

15亿美元再下赌注！中国生物制药创新如何扬帆破浪？

2021-09-20

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

赛诺菲宣布以19亿美元收购美国生物制药公司KDMN，盘前大涨77%！

2021-09-10

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

周报：全球新冠大流行推高生物制药股票10.6%

2021-08-30

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

PD-1/L1竞争再加剧，中国生物制药与康方生物研发的治疗鼻咽癌新药上市申请获国家药监局受理

2021-08-08

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

助力生物制药关键材料国产化，红杉医疗成员企业纳微科技成功IPO

2021-06-25

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

临床阶段生物制药公司宣布开展卡妥索双抗治疗非肌层浸润性膀胱癌临床I/II期试验

2021-04-16

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

超过20家生物制药公司港股上市，如何走出破发怪圈

2020-12-07

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

SciVario® twin双联生物反应器重磅上市，助力生物制药行业高质量发展

2020-11-11

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

重磅！默沙东将分拆为两家公司，专注研发创新生物制药

2020-02-07

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

三叶草生物制药在中国启动Etanercept生物类似物候选产品SCB-808的III期研究

2020-01-02

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

生物制药领域更具价值新药研发项目TOP10

2019-12-27

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

Thermo Fisher在中国开设客户解决方案中心，以支持生物制药研发

2019-11-16

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

德国模式+张江制造：跨国药企在华生物制药商业化合同生产（CMO）服务平台亮相进博会

2019-11-08

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

亚盛医药IPO敲定基石投资人，中国生物制药认购1.4亿元

2019-10-18

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

引领生物制药行业标准，加速高品质创新抗癌药惠及患者 ——百济神州广州生物药生产基地一期项目竣工

2019-09-29

ms6390871039024434 (审核中...)

前往app查看评论内容

#生物制药#

科伦、中国生物制药、信立泰……半年业绩大比拼

2019-08-31

柳叶一刀 (审核中...)

前往app查看评论内容

#生物制药#

生物制药“名人堂”：史上销售额**的超重磅产品盘点

2019-08-17

科室
- - 订阅+
  - 更多科室
工具
服务